Preexposure Prophylaxis and Patient Centeredness

Preexposure Prophylaxis and Patient Centeredness

Preexposure prophylaxis has transformed HIV prevention, becoming widespread in communities of gay and bisexual men in the developed world in a short time. There is a broad concern that preexposure prophylaxis will discourage condom use among gay men (i.e., “risk compensation”). This commentary argue...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Jonathan M. Snowden PhD, Maria I. Rodriguez MD, MPH, Skyler D. Jackson MS, Julia L. Marcus PhD, MPH
Format:	Artykuł
Język:	English
Wydane:	SAGE Publishing 2016-09-01
Seria:	American Journal of Men's Health
Dostęp online:	https://doi.org/10.1177/1557988316658288

Podobne zapisy

Response Rates of Medical Providers to Internet Surveys Regarding Their Adoption of Preexposure Prophylaxis for HIV: Methodological Implications
od: Thomas B. Silverman MPH, i wsp.
Wydane: (2018-09-01)

Using Health Care Professionals’ Perspectives to Refine a Clinical Decision Support Implementation Strategy for Increasing the Prescribing of HIV Preexposure Prophylaxis (PrEP) in Alabama
od: Debbie L. Humphries PhD, MPH, MA, i wsp.
Wydane: (2022-12-01)

The use of preexposure treatments for HIV prophylaxis
od: Majid A, i wsp.
Wydane: (2012-02-01)

Clinical Considerations in the Selection of Preexposure Prophylaxis for HIV Prevention in Canada
od: David C. Knox, i wsp.
Wydane: (2022-01-01)

AIDS vaccines and preexposure prophylaxis: is synergy possible?
od: Excler, J, i wsp.
Wydane: (2011)

HIV Preexposure Prophylaxis Practice among Urban Female Sex Workers in Northwest Ethiopia: Using Generalized Structural Equation Modeling
od: Lakew Asmare MPH, i wsp.
Wydane: (2024-11-01)

Awareness and Willingness to use Condoms and Preexposure Prophylaxis among Gay, Bisexual, and Other Cisgendered Men who Have sex with men in Slum Communities in Ghana. BSGH-004
od: Gamji Rabiu Abu-Ba’are PhD, i wsp.
Wydane: (2023-11-01)

The Impact of Applying Quality Management Practices on Patient Centeredness in Jordanian Public Hospitals: Results of Predictive Modeling
od: Heba H. Hijazi PhD, i wsp.
Wydane: (2018-02-01)

HIV Risk and Interest in Preexposure Prophylaxis in Justice-Involved Persons
od: Ank E. Nijhawan, i wsp.
Wydane: (2024-04-01)

HIV preexposure prophylaxis and postexposure prophylaxis in women: a comprehensive guide for healthcare providers
od: Niam Vora, i wsp.
Wydane: (2024-12-01)

Supporting Access to HIV Pre-Exposure Prophylaxis in a Shifting Financial and Insurance Landscape
od: Connor Eichenwald, MD, MPH, i wsp.
Wydane: (2025-04-01)

HIV Care Continuum and Preexposure Prophylaxis Program in Federal Bureau of Prisons, United States
od: Xiao Hong Huang, i wsp.
Wydane: (2024-04-01)

No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis.
od: Julia L Marcus, i wsp.
Wydane: (2013-01-01)

Substance Use and Adherence to HIV Preexposure Prophylaxis for Men Who Have Sex with Men
od: Martin Hoenigl, i wsp.
Wydane: (2018-12-01)

Patient Centeredness in Orthognathic Surgery
od: Alexandre R. Vieira, i wsp.
Wydane: (2021-02-01)

Preexposure prophylaxis-related stigma: strategies to improve uptake and adherence – a narrative review
od: Haire BG
Wydane: (2015-10-01)

Location Preferences for Accessing Long-Acting Injectable Pre-Exposure Prophylaxis (LA-PrEP) Among Men Who Have Sex With Men (MSM) Currently on Daily Oral PrEP
od: Jennifer L. Glick PhD, MPH, i wsp.
Wydane: (2024-12-01)

Parent Stress in Relation to Use of Bedside Telehealth, an Initiative to Improve Family-Centeredness of Care in the Neonatal Intensive Care Unit
od: Katherine Guttmann MD, MBE, i wsp.
Wydane: (2020-12-01)

Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men.
od: Julia L Marcus, i wsp.
Wydane: (2014-01-01)

Long-acting lenacapavir acts as an effective preexposure prophylaxis in a rectal SHIV challenge macaque model
od: Elena Bekerman, i wsp.
Wydane: (2023-08-01)

Preexposure and Postexposure Prophylaxis of Rabies With Adeno-Associated Virus Expressing Virus-Neutralizing Antibody in Rodent Models
od: Fei Huang, i wsp.
Wydane: (2021-08-01)

Venous Thromboembolism Prophylaxis and Risk for Acutely Medically Ill Patients Stratified by Different Ages and Renal Disease Status
od: Alpesh Amin MD, MBA, i wsp.
Wydane: (2019-01-01)

Awareness and Uptake of HIV Preexposure Prophylaxis and Postexposure Prophylaxis Among College Students With Sexual Experiences: Institutional-Based Cross-Sectional Study
od: Junfang Xu, i wsp.
Wydane: (2024-11-01)

Long-Acting Injectable Cabotegravir for HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: Protocol for an Implementation Study
od: Beatriz Grinsztejn, i wsp.
Wydane: (2023-04-01)

Recommendations for Increasing Physician Provision of Pre-Exposure Prophylaxis: Implications for Medical Student Training
od: Robert L. Cooper PhD, MSSW, i wsp.
Wydane: (2021-05-01)

Risks and Benefits of Preexposure and Postexposure Smallpox Vaccination
od: Martin I. Meltzer
Wydane: (2003-11-01)

“ Healthcare Worker Perspectives on Using pre-Exposure Prophylaxis (PrEP) During Pregnancy and Postpartum in Kenya
od: Nancy Mwongeli MBChB, MPH, i wsp.
Wydane: (2022-06-01)

Potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of HIV-1 infection
od: Gatanaga, H, i wsp.
Wydane: (2017)

132 A Qualitative Exploration of Preexposure Prophylaxis Among Black Women Attending Historically Black Colleges and Universities
od: Marissa Robinson, i wsp.
Wydane: (2022-04-01)

Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study.
od: Andreas B Eisingerich, i wsp.
Wydane: (2012-01-01)

Probenecid‐Boosted Tenofovir: A Physiologically‐Based Pharmacokinetic Model‐Informed Strategy for On‐Demand HIV Preexposure Prophylaxis
od: Stephanie N. Liu, i wsp.
Wydane: (2020-01-01)

Dog bite, immunoglobulin, and preexposure vaccination
od: Nora Pokee, i wsp.
Wydane: (2015-01-01)

Non-Occupational HIV Post-exposure Prophylaxis: A 10-Year Retrospective Review of Data Following Sexual Exposure From Yaounde Central Hospital, Cameroon
od: Charles Kouanfack, MD, PhD, i wsp.
Wydane: (2019-12-01)

Health care providers' decision-making and early adoption of tenofovir alafenamide for HIV preexposure prophylaxis: An inductive qualitative study.
od: Elisabeth Merchant, i wsp.
Wydane: (2024-01-01)

Brief communication: attitudes and preferences of long-acting injectable HIV preexposure prophylaxis among Thai adolescents and young adults
od: Alisa Wongsethanatada, i wsp.
Wydane: (2025-03-01)

HPV vaccination and HIV preexposure prophylaxis (PrEP): Missed opportunities for anal cancer prevention among at risk populations
od: Christopher W. Wheldon
Wydane: (2022-11-01)

Technology-Based Interventions to Promote the HIV Preexposure Prophylaxis (PrEP) Care Continuum: Protocol for a Systematic Review
od: Chenglin Hong, i wsp.
Wydane: (2022-03-01)

Roll-out of first HIV pre-exposure prophylaxis services in the Democratic Republic of the Congo
od: Halli Olsen, MPH, i wsp.
Wydane: (2019-03-01)

Berotralstat for long-term prophylaxis of hereditary angioedema in Japan: Parts 2 and 3 of the randomized APeX-J Phase III trial
od: Daisuke Honda, MD, PhD, i wsp.
Wydane: (2024-03-01)

Lack of Association between Antimicrobial Consumption and Antimicrobial Resistance in a HIV Preexposure Prophylaxis Population: A Cross-Sectional Study
od: Thibaut Vanbaelen, i wsp.
Wydane: (2024-02-01)